Biomarker ID | 1326 |
PMID | 24486077 |
Year | 2014 |
Biomarker | Monoclonal Antibody MIB-1 [Ki-67] |
Biomarker Basis | Expression Based |
Biomolecule | Protein |
Source | Tissue |
Subjects | Humans |
Regulation | Increased with increased risk of death |
Odds Ratio/Hazard Ratio/Relative Risk | HR: 1.10 (95% CI: 1.07-1.13) |
Effect on Pathways | Pathways Include: DNA Damage; Neuroscience; Primary Focal Segmental Glomerulosclerosis FSGS |
Experiment | Progression Vs No Progression |
Type of Biomarker | Prognostic |
Cohort | 451 patients with Radical Prosteactomy out of which 46 experienced progression and 18 died of prostate cancer were included in the study |
Senstivity | NA |
Specificity | NA |
AUC | NA |
Accuracy | NA |
Level Of Significance | p<0.001 |
Method Used | Immunohistochemistry |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Not validated on independent patient dataset |
Technical Name | NA |